For adults with virologically suppressed HIV-1, once-weekly oral islatravir-lenacapavir (ISL/LEN) is noninferior to ...
A once-weekly HIV pill combining the antiretroviral drugs islatravir and lenacapavir is as effective as a widely used ...
Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission
Two more people appear to be free of HIV after stem cell transplants for cancer treatment, according to case presentations ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced ...
HYPERTENSION among adults receiving highly active antiretroviral therapy (HAART) was highly prevalent, affecting 47.4% of participants in a cross-sectional study conducted across three referral ...
MedPage Today on MSN
Two Drugs Matched Three for Untreated HIV
The difference between regimens met the trial's noninferiority threshold ...
The LATA study pitted Cabenuva against a triple therapy in teenagers aged 12 to 19 with HIV in Africa.
A once-weekly oral HIV treatment maintained viral suppression as effectively as a standard once-daily regimen in a phase 3 ...
Once-daily, single-tablet regimens have transformed care for persons living with human immunodeficiency virus type 1 (HIV-1); ...
A man in his early 30s presented with a 4-month history of low-grade fever and chronic dry cough. Three months before ...
Merck & Co., Inc. ( MRK) Discusses HIV Program Updates and Phase III Data from International AIDS Conference August 3, 2026 8:00 AM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results